STOCK TITAN

Polyrizon (PLRZ) CTO trims stake with 2,917-share open-market sale

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Polyrizon Ltd. Chief Technology Officer Tidhar Turgeman reported an open-market sale of 2,917 Ordinary Shares of PLRZ at $10.90 per share. After this transaction, he directly holds 17,518 Ordinary Shares.

According to the filing, this position includes 18 restricted ordinary shares that vest in equal monthly installments and 17,500 restricted ordinary shares that vest in equal quarterly installments, in each case subject to his continued service with the company.

Positive

  • None.

Negative

  • None.
Insider Turgeman Tidhar
Role Chief Technology Officer
Sold 2,917 shs ($32K)
Type Security Shares Price Value
Sale Ordinary Shares 2,917 $10.90 $32K
Holdings After Transaction: Ordinary Shares — 17,518 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 2,917 shares Open-market sale of Ordinary Shares
Sale price $10.90 per share Price for the 2,917 shares sold
Shares owned after sale 17,518 shares Direct Ordinary Share holdings post-transaction
Monthly-vesting restricted shares 18 shares Restricted ordinary shares vesting in equal monthly installments
Quarterly-vesting restricted shares 17,500 shares Restricted ordinary shares vesting in equal quarterly installments
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
restricted ordinary shares financial
"Consists of (1) 18 restricted ordinary shares that vest in equal installments"
Restricted ordinary shares are common stock that cannot be sold or transferred until certain conditions are met—such as a time period passing, performance targets being reached, or regulatory approvals—often issued to employees, founders, or early investors. They matter because those restrictions delay when the shares can enter the market, affecting the future supply of shares, potential dilution and company valuation; think of them as goods locked in a warehouse until release conditions are satisfied.
vest in equal installments financial
"restricted ordinary shares that vest in equal installments on a monthly basis"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
derivative positions financial
"derivativeSummary: []"
Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Turgeman Tidhar

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares03/30/2026S2,917D$10.917,518(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Consists of (1) 18 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (2) 17,500 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service
/s/ Tidhar Turgeman03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Polyrizon (PLRZ) report for CTO Tidhar Turgeman?

Polyrizon reported that CTO Tidhar Turgeman executed an open-market sale of 2,917 Ordinary Shares at $10.90 per share. The transaction is disclosed on a Form 4 and reflects a routine insider sale rather than a grant or option exercise.

How many Polyrizon (PLRZ) shares does the CTO hold after the reported sale?

Following the sale, CTO Tidhar Turgeman directly owns 17,518 Ordinary Shares of Polyrizon. This figure includes his time-vested restricted ordinary shares, which continue to vest over time as long as he remains in service with the company.

What price did the Polyrizon (PLRZ) CTO receive per share in the Form 4 sale?

The CTO’s open-market sale was executed at a price of $10.90 per Ordinary Share. This per-share price, multiplied by the 2,917 shares sold, provides an approximate indication of the cash value realized in this particular insider transaction.

What restricted share awards does the Polyrizon (PLRZ) CTO have outstanding?

The filing notes that the CTO holds 18 restricted ordinary shares vesting monthly and 17,500 restricted ordinary shares vesting quarterly. Both vesting schedules are contingent on his continued service with Polyrizon, providing ongoing equity-based compensation over time.

Is the Polyrizon (PLRZ) CTO’s Form 4 transaction an option exercise or a direct share sale?

The transaction is characterized as an open-market sale of Ordinary Shares, coded as “S” on the Form 4. There is no associated option exercise or derivative conversion reported, and the filing lists no remaining derivative positions in the derivative summary.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

12.38M
1.61M
Biotechnology
Healthcare
Link
Israel
Ra'anana